Targeted radiation plus immunotherapy tested before prostate cancer surgery
Disease control
Terminated
This study tested if adding a new treatment before surgery could help men with very high-risk prostate cancer. The treatment combined a targeted radiation drug (LuPSMA) with or without an immunotherapy drug (ipilimumab). The main goals were to see if surgery could still happen on…
Phase: PHASE1, PHASE2 • Sponsor: University Hospital, Essen • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC